Re: Response
|
3
|
Resverlogix Corp.
|
Jan 23, 2024 08:04PM
|
Response
|
5
|
Resverlogix Corp.
|
Jan 23, 2024 10:11AM
|
Re: Long Covid
|
3
|
Resverlogix Corp.
|
Jan 22, 2024 06:19PM
|
Re: Long Covid
|
5
|
Resverlogix Corp.
|
Jan 22, 2024 05:35PM
|
Re: Disease X
|
3
|
Resverlogix Corp.
|
Jan 22, 2024 01:55PM
|
Re: Disease X
|
4
|
Resverlogix Corp.
|
Jan 22, 2024 09:54AM
|
Re: Long Covid
|
1
|
Resverlogix Corp.
|
Jan 19, 2024 06:57PM
|
Re: Long Covid
|
2
|
Resverlogix Corp.
|
Jan 19, 2024 06:54PM
|
Re: Long Covid
|
1
|
Resverlogix Corp.
|
Jan 18, 2024 09:42PM
|
Re: Epigenetics market size
|
1
|
Zenith Epigenetics
|
Jan 16, 2024 07:41PM
|
Re: Epigenetics market size
|
6
|
Zenith Epigenetics
|
Jan 16, 2024 02:18PM
|
Short Interest-continues to inch down on US side of things..
|
2
|
Resverlogix Corp.
|
Jan 11, 2024 12:34PM
|
Re: RVXs up or down draft from ZENE???
|
2
|
Resverlogix Corp.
|
Jan 11, 2024 10:52AM
|
Re: Resverlogix Announces Publication of its 40th Scientific Journal Article on Apabetalone's Potential Therapeutic Benefits
|
2
|
Resverlogix Corp.
|
Jan 11, 2024 09:44AM
|
Re: Resverlogix Announces Publication of its 40th Scientific Journal Article on Apabetalone's Potential Therapeutic Benefits
|
3
|
Resverlogix Corp.
|
Jan 11, 2024 09:26AM
|
Re: RVXs up or down draft from ZENE???
|
|
Resverlogix Corp.
|
Jan 10, 2024 03:59PM
|
Re: Pfizer seems like a good fit for a BP deal
|
1
|
Zenith Epigenetics
|
Jan 10, 2024 02:55PM
|
Re: RVXs up or down draft from ZENE???
|
|
Resverlogix Corp.
|
Jan 10, 2024 01:19PM
|
Re: Pfizer seems like a good fit for a BP deal
|
1
|
Zenith Epigenetics
|
Jan 10, 2024 01:08PM
|
Re: RVXs up or down draft from ZENE???
|
3
|
Resverlogix Corp.
|
Jan 10, 2024 01:05PM
|